Search is Powered by Google
Cancer / Oncology News

WHO Study: Night Shift Work May Cause Cancer

Main Category: Cancer / Oncology
Also Included In: Public Health
Article Date: 01 Dec 2007 - 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:4 stars

3.67 (3 votes)

Health Professional:4 stars

3.7 (10 votes)

Article Opinions: 0 posts

A study by the World Health Organization has found that night shift work increases the risk of cancer in humans. The study found that after prolonged exposure to night shift work, women are at a higher risk to develop breast and colon cancer. Men who work the night shift are more likely to experience prostate cancer.

"Shift work that interferes with regular nighttime sleep disrupts circadian rhythms, our body's natural clock," said Dr. Erhard Haus of HealthPartners Research Foundation who chaired a subgroup of the study. "This impedes biologic function by suppressing the immune system, reducing melatonin production and may damage genes leading to the production of abnormal cells."

Dr. Haus was part of a team of 24 scientists from ten countries who met at the International Agency for Research on Cancer in Lyon, France, to assess the potential carcinogenicity of shift work, painting, and firefighting. The workgroup analyzed several epidemiologic studies and animal experiments. In addition to their findings on shift work, they determined that overall, occupational exposure as a painter is carcinogenic to humans. They also classified occupational exposure as a firefighter as possibly carcinogenic to humans.

A preliminary report of the WHO International Agency for Research on Cancer (IARC) will appear in Lancet Oncology, December 7, 2007.

Between 15 and 20 percent of the working population in the U.S. and Europe are engaged in shift work, which is most prevalent in the health care, transportation, communication, leisure and hospitality sectors.

About HealthPartners Research Foundation

HealthPartners family of care includes HealthPartners Research Foundation (http://www.hprf.org). Conducting about 250 research projects each year, the Foundation is dedicated to advancing scientific knowledge through research to improve the health of our members and the community. Founded in 1957, HealthPartners (http://www.healthpartners.com) serves more than one million medical and dental health plan members nationwide and is the largest consumer-governed, nonprofit health care organization in the nation, providing care, coverage, research and education to improve the health of members, patients and the community.

HealthPartners
http://www.healthpartners.com




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...